ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2302

Comparison Between Fibromyalgia and Neuropathic Pain in Patients with Established Rheumatoid Arthritis

Yong Gil Hwang1, Lei Zhu 1 and Larry Moreland 1, 1University of Pittsburgh, PITTSBURGH, PA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: fibromyalgia and painDETECT, neuropathic pain, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Our objectives were (1) to identify similarities and differences of pain symptoms identified by fibromyalgia (FM) and neuropathic pain (NP) screening tool (2) to compare pain qualities and their relationship with rheumatoid arthritis (RA) disease activity.

Methods: 169 RA patients enrolled in the University of Pittsburgh Rheumatoid Arthritis Comparative Effectiveness Registry (RACER) underwent a clinical evaluation and fulfilled 3 self-report questionnaires (PainDETECT, Patient-Reported Outcomes Measurement Information System (PROMIS) 29, Widespread Pain Index/Symptom Severity Scale). The results of the clinical evaluation and questionnaires were then compared.

Results: 20 patients (11.8%) met the fibromyalgia criteria, whereas 16 patients (9.6%) were found to have neuropathic pain. However, only three patients were categorized as FM among those patients who were classified as NP. PainDETECT and polysomatic distress score were significantly correlated with pain levels, RA disease activity, and all PROMIS domains. (Figure 1) No significant difference in the swollen joint count was found regardless of the presence or absence of FM or NP. Tender joint count, patient & physician global disease assessment (PtGD, PhyGD), and clinical disease activity index (CDAI) were significantly higher in patients with NP vs those without NP, whereas only PtGD was higher in patients with FM vs those without FM. (Table 1) Significantly higher scores were found for all PROMIS domains and sensory profiles in patients with NP, while anxiety, depression, fatigue, pain interference, and slight pressure-associated pain were increased in patients with FM. (Table 2)

Conclusion: This study highlights the differences between FM and NP in association with RA disease activity and PROMIS29 domains and demonstrates the PainDETECT can be a useful tool in identifying clinical phenotypes of RA patients.

A. Correlation matrix among painDEDECT, polysomatic distress score, and clinical disease activity index B. Correlation matrix among PainDETECT, polysomatic distress score, and patient-reported outcomes measurement information system 29 domains -PDQ: PainDETECT questionnaire, PSD: polysomatic distress score, SJC: swollen joint count, TJC: tender joint count, PhyGD: physician global disease assessment, PtGD: patient global disease assessment, CDAI: clinical disease activity index, Discrepancy: absolute value for discrepancy between PhyGD and PtGD, RA: rheumatoid arthritis, PROMIS: Patient-reported outcomes measurement information system, PFA: physical function, ANX: anxiety, DEP: depression, FTG: fatigue, SLP: sleep disturbance, SRP: Abilities to participate in social role, PIN: pain interference, PAIN: 1-wk average pain level-


Table 1_2019

Table 1 Demographics and comparison of clinical characteristics of subgroups based on the fibromyalgia and PainDETECT categories -Mean -SD–


Disclosure: Y. Hwang, None; L. Zhu, None; L. Moreland, None.

To cite this abstract in AMA style:

Hwang Y, Zhu L, Moreland L. Comparison Between Fibromyalgia and Neuropathic Pain in Patients with Established Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/comparison-between-fibromyalgia-and-neuropathic-pain-in-patients-with-established-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-between-fibromyalgia-and-neuropathic-pain-in-patients-with-established-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology